Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Metabolic Effects of Gastrectomy and Duodenal Bypass in Early Gastric Cancer Patients with T2DM: A Prospective Single-Center Cohort Study.

Tytuł:
Metabolic Effects of Gastrectomy and Duodenal Bypass in Early Gastric Cancer Patients with T2DM: A Prospective Single-Center Cohort Study.
Autorzy:
Lee YK; Division of Endocrinology and Metabolism, Department of Internal Medicine, National Cancer Center, Goyang 10408, Korea.
Lee EK; Division of Endocrinology and Metabolism, Department of Internal Medicine, National Cancer Center, Goyang 10408, Korea.; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Korea.
Lee YJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, National Cancer Center, Goyang 10408, Korea.
Eom BW; Center for Gastric Cancer, National Cancer Center, Goyang 10408, Korea.
Yoon HM; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Korea.; Center for Gastric Cancer, National Cancer Center, Goyang 10408, Korea.
Kim YI; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Korea.; Center for Gastric Cancer, National Cancer Center, Goyang 10408, Korea.
Cho SJ; Center for Gastric Cancer, National Cancer Center, Goyang 10408, Korea.
Lee JY; Center for Gastric Cancer, National Cancer Center, Goyang 10408, Korea.
Kim CG; Center for Gastric Cancer, National Cancer Center, Goyang 10408, Korea.
Kong SY; Department of Cancer Biomedical Science, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Korea.; Department of Laboratory Medicine, National Cancer Center, Goyang 10408, Korea.
Yoo MK; Department of Clinical Nutrition, National Cancer Center, Goyang 10408, Korea.
Hwangbo Y; Division of Endocrinology and Metabolism, Department of Internal Medicine, National Cancer Center, Goyang 10408, Korea.; Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Korea.
Kim YW; Center for Gastric Cancer, National Cancer Center, Goyang 10408, Korea.
Choi IJ; Center for Gastric Cancer, National Cancer Center, Goyang 10408, Korea.; Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang 10408, Korea.
Kim HJ; Division of Cardiology, Department of Internal Medicine, National Cancer Center, Goyang 10408, Korea.
Kwak MH; Division of Cardiology, Department of Internal Medicine, National Cancer Center, Goyang 10408, Korea.
Ryu KW; Center for Gastric Cancer, National Cancer Center, Goyang 10408, Korea.
Źródło:
Journal of clinical medicine [J Clin Med] 2021 Sep 04; Vol. 10 (17). Date of Electronic Publication: 2021 Sep 04.
Typ publikacji:
Journal Article
Język:
English
Imprint Name(s):
Original Publication: Basel, Switzerland : MDPI AG, [2012]-
References:
Obes Surg. 2020 Dec;30(12):4829-4833. (PMID: 32996102)
J Clin Endocrinol Metab. 2009 Sep;94(9):3171-82. (PMID: 19509100)
Horm Metab Res. 2020 Apr;52(4):207-215. (PMID: 32268422)
Diabetes Care. 2011 Jan;34 Suppl 1:S11-61. (PMID: 21193625)
Diabetes Metab J. 2021 Jan;45(1):1-10. (PMID: 33434426)
Obes Surg. 2019 Aug;29(8):2492-2502. (PMID: 30972637)
Cell. 2014 Dec 4;159(6):1404-16. (PMID: 25480301)
World J Gastroenterol. 2014 Dec 28;20(48):18427-31. (PMID: 25561812)
Obes Surg. 2019 Mar;29(3):964-974. (PMID: 30402804)
CA Cancer J Clin. 2018 Nov;68(6):394-424. (PMID: 30207593)
Cancer Res Treat. 2020 Apr;52(2):335-350. (PMID: 32178489)
Br J Surg. 2018 Feb;105(3):168-181. (PMID: 29405276)
Asia Pac J Clin Oncol. 2016 Mar;12(1):e47-56. (PMID: 24354451)
Diabetes Care. 2016 Jun;39(6):924-33. (PMID: 27222550)
World J Gastroenterol. 2012 Jan 7;18(1):49-54. (PMID: 22228970)
N Engl J Med. 2014 May 22;370(21):2002-13. (PMID: 24679060)
Thromb J. 2018 Jun 5;16:12. (PMID: 29991926)
J Gastric Cancer. 2019 Mar;19(1):1-48. (PMID: 30944757)
Gastroenterology. 2017 May;152(6):1319-1328.e7. (PMID: 28147224)
Cancer. 2014 May 1;120(9):1290-314. (PMID: 24343171)
Obes Surg. 2019 Apr;29(4):1105-1116. (PMID: 30604080)
Acta Pharmacol Sin. 2018 Jul;39(7):1176-1188. (PMID: 29877321)
Obes Surg. 2019 Jul;29(7):2180-2190. (PMID: 31037599)
World J Gastroenterol. 2015 Jan 28;21(4):1173-81. (PMID: 25632190)
JAMA Oncol. 2018 Aug 1;4(8):1099-1105. (PMID: 29879271)
JAMA. 2013 Jun 5;309(21):2240-9. (PMID: 23736733)
Diabetes Res Clin Pract. 2018 Apr;138:271-281. (PMID: 29496507)
Asian J Surg. 2020 Jan;43(1):297-303. (PMID: 31060769)
Ann Intern Med. 2010 Jan 19;152(2):93-100. (PMID: 20083828)
Surg Endosc. 2013 Aug;27(8):2829-35. (PMID: 23436087)
Obes Surg. 2017 Oct;27(10):2724-2732. (PMID: 28801703)
PLoS One. 2019 Dec 3;14(12):e0224828. (PMID: 31794559)
World J Gastroenterol. 2013 Feb 14;19(6):936-45. (PMID: 23429469)
N Engl J Med. 2012 Apr 26;366(17):1567-76. (PMID: 22449319)
Endocrinol Metab (Seoul). 2018 Mar;33(1):33-43. (PMID: 29589386)
Qual Life Res. 2020 Jun;29(6):1483-1494. (PMID: 31938965)
PLoS One. 2017 Dec 7;12(12):e0188904. (PMID: 29216250)
Grant Information:
1210552-3 Republic of Korea National Cancer Center; 1510740-1 Republic of Korea National Cancer Center; 1410650-1 Republic of Korea National Cancer Center
Contributed Indexing:
Keywords: early gastric cancer; endoscopic submucosal dissection; gastrectomy; glycemic control; insulin resistance; type 2 diabetes mellitus
Entry Date(s):
Date Created: 20210910 Latest Revision: 20210913
Update Code:
20240105
PubMed Central ID:
PMC8432535
DOI:
10.3390/jcm10174008
PMID:
34501456
Czasopismo naukowe
We evaluated the metabolic effects of gastrectomies and endoscopic submucosal dissections (ESDs) in early gastric cancer (EGC) patients with type 2 diabetes mellitus (T2DM). Forty-one EGC patients with T2DM undergoing gastrectomy or ESD were prospectively evaluated. Metabolic parameters in the patients who underwent gastrectomy with and without a duodenal bypass (groups 1 and 2, n = 24 and n = 5, respectively) were compared with those in patients who underwent ESD (control, n = 12). After 1 year, the proportions of improved/equivocal/worsened glycemic control were 62.5%/29.2%/8.3% in group 1, 40.0%/60.0%/0.0% in group 2, and 16.7%/50.0%/33.3% in the controls, respectively ( p = 0.046). The multivariable ordered logistic regression analysis results showed that both groups had better 1-year glycemic control. Groups 1 and 2 showed a significant reduction in postprandial glucose (-97.9 and -67.8 mg/dL), body mass index (-2.1 and -2.3 kg/m 2 ), and glycosylated hemoglobin (group 1 only, -0.5% point) (all p < 0.05). Furthermore, improvements in group 1 were more prominent when preoperative leptin levels were high ( p for interaction < 0.05). Metabolic improvements in both groups were also observed for insulin resistance, leptin, plasminogen activator inhibitor-1, and resistin. Gastrectomy improved glycemic control and various metabolic parameters in EGC patients with T2DM. Patients with high leptin levels may experience greater metabolic benefits from gastrectomy with duodenal bypass.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies